News Release

Zogenix to Release Fourth Quarter and Full-Year 2015 Financial Results and Host Conference Call and Webcast on March 10


EMERYVILLE, Calif., March 04, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2015 after the market close, and will host a corporate update conference call and webcast on Thursday, March 10th at 4:30 PM Eastern Time.

Thursday, March 10th @ 4:30 PM Eastern Time/1:30 PM Pacific Time
Toll Free: 888-337-8198
International: 719-325-2308
Conference ID: 5464024
Replays, available through March 24, 2016:
Domestic: 877-870-5176
International: 858-384-5517
Conference ID: 5464024

About Zogenix
Zogenix, Inc. (NASDAQ:ZGNX) is an innovative pharmaceutical company committed to providing unique therapeutic solutions for people living with rare and burdensome disease conditions. Our focused strategy centers on advancing late-stage, high-value products for CNS disorders that will significantly improve outcomes for patients and physicians.

For more information, visit

Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 |

Zogenix, Inc.